Bio
Dr. Killcommons serves as the founder and CEO of Medweb, a San Francisco-based medical imaging company that he founded in 1992. Early in his career, Dr. Killcommons worked toward his goal of linking hospitals through technology and expanded on DICOM (digital imaging and communication in medicine). In 1994, Dr. Killcommons received a grant from Pacific Bell for this purpose. The San Francisco Chronicle subsequently featured the entrepreneur in its business section. Today, Dr. Killcommons and Medweb offer medical imaging, teleradiology, and telemedicine technology. Medweb’s products are often used by the U.S. military. Also a dedicated humanitarian, Dr. Killcommons has traveled to Antigua, Peru, and the rural areas of Kuwait and Afghanistan. He has donated his time, skills, and equipment to provide medical care to those in need. Dr. Peter Killcommons remains the only CEO of a medical firm to travel to war zones in order to ensure adequate medical care and equipment for U.S. soldiers. In addition to bringing digital imaging technology to developing countries, Dr. Peter Killcommons has introduced solar power and light-emitting diode (LED) technology to many of these areas, including Kabul and Jalalabad in Afghanistan. Prior to his professional endeavors, Dr. Killcommons enrolled in an accelerated Bachelor of Science/Doctor of Medicine program, offered at the City College of New York Sophie Davis School of Biomedical Education in partnership with New York Medical College. In 1984, he graduated cum laude. In addition to his medical and technological expertise, Dr. Peter Killcommons also serves as an experienced pilot, scuba diver, and first responder. Dr. Peter Killcommons earned recognition for new technology that he helped to pioneer for medical purposes, using a “cloud storage” system to store and manage data on multiple servers.
Sessions
-
AR case studies in healthcare moderated by ODG Panel03:15 PM - 04:00 PM Jun 2Medical professionals and patients are leading the way in pilot programs and deployment of Smartglasses. Join us for a discussion of current and forthcoming ventures.